Daiichi Sankyo, Inc. is a global pharmaceutical company that focuses on the research and development of innovative medications. With a strong presence in the healthcare industry, the company is committed to improving the quality of life for patients worldwide through its cutting-edge pharmaceutical solutions.

The company places a significant emphasis on sustainability and corporate responsibility. Daiichi Sankyo has implemented various initiatives to reduce its environmental impact, including efforts to minimize waste and lower carbon emissions. The company is actively working towards achieving its sustainability goals by integrating eco-friendly practices into its operations.

Daiichi Sankyo's commitment to sustainability is reflected in its participation in global environmental programs and adherence to international standards. The company has been recognized for its efforts in promoting sustainable practices and continues to strive for improvements in its environmental performance.

While specific details on their ESG reports and carbon footprint calculations are limited, Daiichi Sankyo's ongoing dedication to sustainability is evident in its continuous efforts to enhance its environmental and social governance.